This study is not yet accepting patients
EVR and EPO for Liver Transplant Tolerance
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Sandy Feng, MD, PhD
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Sandy Feng, MD, PhD
Dr. Sandy Feng is a transplant surgeon who performs liver, kidney and pancreas transplants. In her research, Feng studies transplantation tolerance, a transplant recipient's ability to maintain normal organ function with minimal or no use of immunosuppressive drugs.
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Links
- Immune Tolerance Network (ITN) National Institute of Allergy and Infectious Diseases (NIAID) Division of Allergy, Immunology, and Transplantation (DAIT)
- ID
- NCT06832189
- Phase
- Phase 1 Liver Transplant Research Study
- Study Type
- Interventional
- Participants
- Expecting 20 study participants
- Last Updated